← Latest Filings
D

Davidson Michael H.

Chief Executive Officer

Open-market buys
1
$227K total
Open-market sells
8
$25.3M total
Tracking since
Feb 2026
Open-market buy — $227K
Open-market sale — $14.8M
Open-market trades from the last two years.
364,000 Option (right to buy) in NAMS
Held directly · as of 2026-01-07
285,715 Ordinary Shares in NAMS
Held indirectly (See footnote) · as of 2026-09-14
NewAmsterdam Pharma Co N.V.
CIK 0001936258
TENAX THERAPEUTICS, INC.
CIK 0000034956